InflaRx N.V.'s long-term debt is $560K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest long-term debt for IFRX is $560K as of June 2026. That compares with $200K in the prior-year period — up 174.8% year over year. Investors often review this figure alongside InflaRx N.V.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, IFRX's long-term debt moved from $200K to $560K — a 174.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in InflaRx N.V.'s operating scale or balance-sheet position.
A long-term debt figure of $560K for IFRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting IFRX's long-term debt ($560K), review year-over-year change from $200K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack InflaRx N.V.'s long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.